account_id none on file
legal_name Rocket Pharmaceuticals, Inc.
ticker RCKT
cik 1281895
domain rocketpharma.com
linkedin_company_url https://www.linkedin.com/company/rocket-pharmaceuticals-ltd
entry_point_account_id none on file
name Rocket Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
hq New York, NY, United States
sector index/company/sector/health-care/
calls 0 filings 12 executives 2 family 0
why_nownone on file
callsnone on file
filings
General and administrative expenses consist primarily of salaries and related benefit costs for personnel, including stock-based compensation and travel expenses for our employees in commercial, executive, operational, finance, legal, business development, and human resource functions.
filing / Aug 10, 2026 / receipt
As part of this strategic realignment, we de-prioritized further development activities related to our FA and PKD programs and implemented a workforce reduction of approximately 30%.
filing / Aug 10, 2026 / receipt
In June 2025, the Company’s Board of Directors approved a restructuring plan to reduce the Company’s workforce and incurred aggregate charges of approximately $3.5 million in restructuring expenses, consisting of employee severance payments and other termination benefits.
filing / Aug 10, 2026 / receipt
General and administrative expenses consist primarily of salaries and related benefit costs for personnel, including stock-based compensation and travel expenses for our employees in commercial, executive, operational, finance, legal, business development, and human resource functions.
filing / Aug 10, 2026 / receipt
As part of this strategic realignment, we de-prioritized further development activities related to our FA and PKD programs and implemented a workforce reduction of approximately 30%.
filing / Aug 10, 2026 / receipt
In June 2025, the Company’s Board of Directors approved a restructuring plan to reduce the Company’s workforce and incurred aggregate charges of approximately $3.5 million in restructuring expenses, consisting of employee severance payments and other termination benefits.
filing / Aug 10, 2026 / receipt
General and administrative expenses consist primarily of salaries and related benefit costs for personnel, including stock-based compensation and travel expenses for our employees in commercial, executive, operational, finance, legal, business development, and human resource functions.
filing / May 7, 2026 / receipt
As part of this strategic realignment, we de-prioritized further development activities related to our FA and PKD programs and implemented a workforce reduction of approximately 30%.
filing / May 7, 2026 / receipt
In June 2025, the Company’s Board of Directors approved a restructuring plan to reduce the Company’s workforce and incurred aggregate charges of approximately $3.2 million in restructuring expenses, consisting of employee severance payments and other termination benefits.
filing / May 7, 2026 / receipt
General and administrative expenses consist primarily of salaries and related benefit costs for personnel, including stock-based compensation and travel expenses for our employees in commercial, executive, operational, finance, legal, business development, and human resource functions.
filing / May 7, 2026 / receipt
As part of this strategic realignment, we de-prioritized further development activities related to our FA and PKD programs and implemented a workforce reduction of approximately 30%.
filing / May 7, 2026 / receipt
In June 2025, the Company’s Board of Directors approved a restructuring plan to reduce the Company’s workforce and incurred aggregate charges of approximately $3.2 million in restructuring expenses, consisting of employee severance payments and other termination benefits.
filing / May 7, 2026 / receipt
executives
| Gaurav Shah | President and Chief Executive Officer | - | receipt |
| Peter Fong | President | - | receipt |
familynone on file
upcoming
| 2026-11-05 | earnings call | scheduled | ir |
changes
| 2025-09-29 | President, appointed | sec_8k |
| 2025-08-25 | Chief Financial Officer, departed | sec_8k |
| 2018-01-05 | President and Chief Executive Officer, appointed | sec_8k |
mcp_package_hint
slug rocket-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$